Neuraly Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 2B Trial Live HarderSep 15, 20211 min readhttps://www.businesswire.com/news/home/20201102005054/en/Neuraly-Receives-FDA-Clearance-of-Investiga
Fibroblast growth factor 1 (FGF-1) to possibly treat Parkinson's Diseasehttps://l.facebook.com/l.php?u=https%3A%2F%2Fwww.pd-studies.com%2F%3Fmibextid%3DZxz2cZ%26fbclid%3DIwAR27vhRZpwK1dhqVX2clQRnTmpp7xGVKM16XC...
Common Bacteria Could Be The Main Cause of Parkinson's Diseasehttps://l.facebook.com/l.php?u=https%3A%2F%2Fwww.iflscience.com%2Fcommon-bacteria-could-be-the-main-cause-of-parkinsons-disease-68821%3Ff...
Artificial Intelligence study and Parkinson'shttps://www.parkinson.org/blog/science-news/artificial-intelligence
Comments